| 03.04.2024 07:00 | AGY | Director Resignation | RNS |
| 27.03.2024 16:13 | LPA, LDSG, SOLI | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | Alliance |
| 27.03.2024 11:02 | IIP, AGY, NBB | AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue | Alliance |
| 27.03.2024 07:00 | AGY | Update on funding | RNS |
| 27.03.2024 07:00 | AGY | Interim Results for six months ended 31 Dec 2023 | RNS |
| 12.03.2024 14:06 | AGY | Allergy Therapeutics starts dosing patients in peanut allergy trial | Alliance |
| 12.03.2024 08:59 | AGY | VLP Peanut PROTECT Trial Update | RNS |
| 12.03.2024 07:00 | AGY | VLP Peanut PROTECT Trial Update | Reach |
| 11.03.2024 07:00 | AGY | Appointment of Shaun Furlong to Board of Directors | RNS |
| 08.03.2024 13:49 | AGY | Result of AGM | RNS |
| 01.03.2024 15:49 | SCP, NEO, TORO | UK shareholder meetings calendar - next 7 days | Alliance |
| 14.02.2024 10:22 | AGY | Allergy Therapeutics forecasts revenue drop but trials going well | Alliance |
| 14.02.2024 07:00 | AGY | Half-Year Trading Update 2024 | RNS |
| 09.02.2024 15:07 | AGY | Notice of 2023 Annual General Meeting | RNS |
| 05.02.2024 14:09 | APH, AGY, SCLP | TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down | Alliance |
| 30.01.2024 10:38 | AGY | Allergy Therapeutics resumes trading on AIM; annual revenue plunges | Alliance |
| 30.01.2024 07:30 | AGY | Restoration - Allergy Therapeutics plc | RNS |
| 30.01.2024 07:00 | AGY | Publication of Annual Report and Accounts 2023 | RNS |
| 04.01.2024 12:29 | AGY | Total Voting Rights | RNS |
| 02.01.2024 07:30 | AGY | Suspension - Allergy Therapeutics plc | RNS |
| 27.12.2023 14:17 | AGY | IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue | Alliance |
| 27.12.2023 12:01 | AGY | Amendment to existing Facility Agreement | RNS |
| 15.12.2023 21:09 | DCTA, AGY, BRH | EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens | Alliance |
| 15.12.2023 12:48 | AGY | Annual Report and Accounts Delayed | RNS |
| 13.12.2023 16:54 | AGY | PDMR dealing and Total Voting Rights | RNS |
| 13.12.2023 10:11 | AGY | Allergy Therapeutics shares jump as hails grass allergy jab data | Alliance |
| 13.12.2023 09:55 | FME, AGY | AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer | Alliance |
| 13.12.2023 07:00 | AGY | G306 Phase III trial meets key endpoints | RNS |
| 11.12.2023 10:45 | AGY, DKL, SNX | AIM WINNERS & LOSERS: Synectics to beat forecast; Dekel shares jump | Alliance |
| 11.12.2023 10:40 | AGY | IN BRIEF: Allergy Therapeutics stock falls on lower sales outlook | Alliance |
| 11.12.2023 07:00 | AGY | Update on funding | RNS |
| 01.12.2023 07:00 | AGY | Total Voting Rights | RNS |
| 28.11.2023 15:03 | AGY | Holding(s) in Company | RNS |
| 14.11.2023 11:56 | AGY | Allergy Therapeutics says allergy therapy trial meets primary endpoint | Alliance |
| 14.11.2023 10:59 | RENX, AGY, HZM | AIM WINNERS & LOSERS: Renalytix revenue halves; DP Poland trades well | Alliance |
| 14.11.2023 07:00 | AGY | G306 Grass Phase III trial meets primary endpoint | RNS |
| 10.11.2023 14:39 | AGY | Form 8.5 (EPT/RI) | RNS |
| 10.11.2023 13:22 | AGY | Director/PCA Dealing | RNS |
| 10.11.2023 13:11 | AGY | Holding(s) in Company | RNS |
| 10.11.2023 07:00 | AGY | Offer Closure | RNS |
| 09.11.2023 10:48 | AGY | Exercise of Options and Total Voting Rights | RNS |
| 09.11.2023 09:24 | AGY | Form 8.5 (EPT/RI) | RNS |
| 09.11.2023 09:15 | AGY | Form 8.5 (EPT/NON-RI) | RNS |
| 08.11.2023 10:45 | AGY | Form 8.5 (EPT/RI) | RNS |
| 07.11.2023 11:10 | AGY | Form 8.5 (EPT/RI) | RNS |
| 06.11.2023 12:33 | AGY | IN BRIEF: Allergy Therapeutics extends cash runway until end of 2023 | Alliance |
| 06.11.2023 09:33 | AGY | Form 8.5 (EPT/RI) | RNS |
| 06.11.2023 07:00 | AGY | Update on funding | RNS |
| 03.11.2023 09:31 | AGY | Form 8.5 (EPT/RI) | RNS |
| 02.11.2023 10:24 | AGY | Form 8.5 (EPT/RI) | RNS |
| 01.11.2023 10:23 | AGY | Form 8.5 (EPT/RI) | RNS |
| 31.10.2023 08:30 | AGY | Form 8.5 (EPT/RI) | RNS |
| 30.10.2023 10:06 | AGY | Form 8.5 (EPT/RI) | RNS |
| 27.10.2023 11:33 | AGY | Form 8.5 (EPT/RI) | RNS |
| 26.10.2023 10:07 | AGY | Form 8.5 (EPT/RI) | RNS |
| 25.10.2023 09:48 | AGY | Form 8.5 (EPT/NON-RI) | RNS |
| 25.10.2023 08:43 | AGY | Form 8.5 (EPT/RI) | RNS |
| 24.10.2023 08:29 | AGY | Form 8.5 (EPT/RI) | RNS |
| 23.10.2023 08:23 | AGY | Form 8.5 (EPT/RI) | RNS |
| 20.10.2023 17:17 | AGY | Holding(s) in Company | RNS |
| 20.10.2023 09:02 | AGY | Form 8.5 (EPT/RI) | RNS |
| 19.10.2023 08:38 | AGY | Form 8.5 (EPT/RI) | RNS |
| 19.10.2023 07:00 | AGY | Posting of Offer Document | RNS |
| 18.10.2023 08:34 | AGY | Form 8.5 (EPT/RI) | RNS |
| 17.10.2023 10:31 | AGY | Form 8.5 (EPT/RI) | RNS |
| 16.10.2023 17:39 | AGY | Southern Fox: Form 8.3 – Allergy Therapeutics Plc | RNS |
| 16.10.2023 15:03 | AGY | Holding(s) in Company | RNS |
| 16.10.2023 14:42 | AGY | Form 8.5 (EPT/RI) | RNS |
| 16.10.2023 12:42 | AGY | Form 8.5 (EPT/NON-RI) | RNS |
| 16.10.2023 11:17 | AGY | Form 8 (DD) - Allergy Therapeutics plc | RNS |
| 16.10.2023 08:40 | AGY | ZQ makes mandatory offer for Allergy Therapeutics as holding hits 60% | Alliance |
| 16.10.2023 08:29 | AGY | Form 8.5 (EPT/RI) | RNS |
| 16.10.2023 08:01 | AGY | Unconditional Mandatory Cash Offer | RNS |
| 13.10.2023 14:07 | AGY | IN BRIEF: Allergy Therapeutics raises GBP40.8 million in fundraise | Alliance |
| 13.10.2023 07:00 | AGY | Result of Open Offer and Subscription | RNS |
